Stem, Inc.
New York Stock Exchange•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Company Description
- CEO
- Mr. Arun Narayanan
- Full Time Employees
- 569
- Sector
- Technology
- Industry
- Software - Infrastructure
- Address
- 100 California Street San Francisco CA United States of America 94111
- IPO Date
- Oct 8, 2020
- CIK
- 0001758766
- Website
- stem.com
- Similar Companies
- Business
- Stem, Inc. operates as a digitally connected and intelligent energy storage network provider in the United States and internationally. It offers energy storage systems sourced from original equipment manufacturers (OEMs). The company also provides Athena, an artificial intelligence platform, which offers battery hardware and software-enabled services to operate the energy storage systems. In addition, it offers system design and engineering services, supply chain management, energy storage value stream optimization, warranty and preventive maintenance plan management, operation and maintenance reporting, and program enrollment and incentive management services. The company serves commercial and industrial enterprises, independent power producers, renewable project developers, and utilities and grid operators. Stem, Inc. was incorporated in 2009 and is headquartered in San Francisco, California.
Company News
Watch These Renewable Energy & Battery Energy Stocks for Valuable Gains
Stem PowerTrack™ Scales Norbut Solar Farms' Community Solar Development and EPC Growth
Stem, Inc. Announces 1-for-20 Reverse Stock Split
Stem Announces Support of One of Nation's Largest Solar-Plus-Storage Projects
MiNK Therapeutics Awarded Prestigious NIAID Grant to Advance Allo-iNKT Cell Therapy for Prevention of GvHD in Stem Cell Transplant Patients
Voltron Therapeutics, Inc., a Lucius Partners Portfolio Company, Announces Definitive Proof of Concept Data for its Second Oncology Candidate (VTX-0P4) in a Prostate Stem Cell Antigen (PSCA) Related Tumor Study in Combination with a Checkpoint Inhibitor (CPI) / anti-mPD-1
Bears are Losing Control Over Stem (STEM), Here's Why It's a 'Buy' Now
Plant Stem Cell Market Review 2020-2024 and Forecast 2025-2030: Unilever, Renature Skin Care, and Other Key Players Leading the Industry
Stem Jumps 32% in a Month: Should You Add the Stock to Your Portfolio?
ASME and ComEd Bring STEM to Life for Fifth and Sixth Graders
Here Is Why Bargain Hunters Would Love Fast-paced Mover Stem (STEM)
Renewable Energy & Battery Storage Stocks to Add to Your Portfolio Now
FDA Accepts Resubmission of BLA for Narsoplimab for Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (TA-TMA) and Assigns Late September PDUFA Date
Stem, Inc. (STEM) Reports Q1 Loss, Tops Revenue Estimates
Stem, Inc. (STEM) Q1 2025 Earnings Call Transcript
Stem Announces First Quarter 2025 Results
Stem to Report Q1 Earnings: What's in the Cards for the Stock?
Stem Announces First Quarter 2025 Results Conference Call
International Stem Cell Corporation Announces 2024 Fourth Quarter and Year-End Results
Stem Drops 13% in a Month: Are the Shares Worth Buying on the Dip?